Bio Innovations APAC

Taking place in Singapore on 4-5 March, the first ever Bio Innovations APAC will connect over 200 bio-pioneers from across the value chain for two days of pre-arranged, commercially focused 1-2-1 meetings.  

With a focus on forging the commercial connections needed to scale industrial biomanufacturing in Asia-Pacific, it is the perfect event for companies involved with or interested in bio-based chemicals, ingredients, and materials and who are looking to meet new customers, partners and solutions, grow business development pipelines and scale at a faster rate. 

Some of the companies already confirmed to attend include Leaf Bio, RWDC, Braskem, MCE, Cauldron, MojiaBio, Newrea Bio, Kemvera, Futurity, Godavari, Godrej Industries, IFF,  lululemon, Licella Holdings, Alt. Leather, Noroo Holdings, Kimberley-Clark, Novonesis, Alfa Laval, BASF and more. 

Unlike typical conferences, Bio Innovations APAC is built around high-value, pre-arranged 1-2-1 meetings – designed to spark strategic partnerships and drive commercial deals. 

So if you are looking to meet these companies and many more at an event designed to help move bio-based solutions from lab to market, you need to be at Bio Innovations APAC. 

Lux-Hosted Panel Session: 

APAC’s Legislative Landscape: What Current and Future Policies Mean for Commercialisation and Growth

Across APAC, governments are introducing regulatory frameworks to support industrial biomanufacturing, but approaches differ widely, creating both challenges and opportunities. This session brings together regional industry associations to explore how these policies influence commercialisation, investment, and scaling strategies. Panellists will highlight where regulations are enabling growth, where they are slowing progress, and what practical changes are needed to build a competitive, investment-ready biomanufacturing across the region.

Hosted by Varsha Sethuraman, Senior Research Associate at Lux Research

Date: Day 1, 4 March
Time: 10:30 – 11:00 (30 minutes)
Other Panelists: 

• Satoshi Nakagawa, Director, Business Development Department, Japan Bioindustry Association

• In-Joo Chin, President and Professor Emeritus, Korean Bioplastics Association

• Panit Kitsubun, Director of the Industrial Bioprocess Innovation Group (IBIG), BIOTEC (NSTDA), Thailand

• Fanny Liao, Board Director, Association of Taiwan Bio-based and Sustainable Material Industry